Recently, the preparatory meeting for the Transdermal Drug Delivery Technology Branch of the China Medical Pharmaceutical Material Association (CMPMA) was held at the Beijing headquarters of Liansnpharm, aiming to integrate industry resources and promote innovation and development of transdermal drug delivery technology. Ms. Julie Gao, President of Leadingpharm, was invited to attend the event and join hands with fellow pharmaceutical colleagues to celebrate the grand event.

As a leader in the pharmaceutical research and development industry, Leadingpharm has always been committed to promoting innovation and development in the field of pharmaceutical research and development. The company has established a transdermal drug delivery technology platform, with rich technical experience and a professional team. During the preparation process of the Transdermal Drug Delivery Technology Branch, Ms. Julie Gao, President of Leadingpharm, shared the research progress and practical experience in the field of transdermal drug delivery, and put forward constructive suggestions on how to promote the efficient commercial transformation of this technology and enhance product competitiveness.
 

The Transdermal Drug Delivery Technology Branch will gather drug research and development enterprises, drug production enterprises, pharmaceutical colleges, renowned experts and professors, hospitals, marketing and promotion enterprises, pharmaceutical equipment enterprises, raw material enterprises, international transdermal drug delivery related organizations, and other units, focusing on innovative research and commercial value transformation of transdermal drug delivery technology. It is committed to building an exchange platform for research, production, and sales in the segmented field of transdermal drug delivery in China, and providing technical cooperation, project investment, research and development outsourcing, raw and auxiliary package supply, production commissioning, instrument equipment, and product sales and other cooperative support services for members. Simultaneously carry out international transdermal technology introduction and high-quality product introduction, promoting the sustainable development of transdermal drug delivery technology and products in China.
 

-END-